Skip to content
Operation Infinite Justice – Lifestyle
Author:
BillionToOne/Biocom
BillionToOne to Participate in the Piper Sandler 38th Annual Healthcare Conference
November 18, 2026
BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance
November 4, 2026
BillionToOne to Participate in Two Upcoming Investor Conferences
October 27, 2026
BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026
October 14, 2026
BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds
October 9, 2026
BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference
September 2, 2026
BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin
September 1, 2026
/C O R R E C T I O N — BillionToOne/
August 19, 2026
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
August 18, 2026
BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
July 20, 2026
1
2
Next Page
→